Terms: = Gastric cancer AND FBXO11, MGC44383, 80204, ENSG00000138081, Q86XK2, VIT1, UG063H01, PRMT9, FLJ12673, FBX11
4 results:
1. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration of gastric adenocarcinoma cells.
Kim YJ; Jeong S; Jung WY; Choi JW; Hwang KC; Kim SW; Lee YC
Int J Med Sci; 2020; 17(6):693-701. PubMed ID: 32218690
[TBL] [Abstract] [Full Text] [Related]
2. LINC01436, regulating miR-585 and fbxo11, is an oncogenic lncRNA in the progression of gastric cancer.
Zhang Y; Yang G; He X; Chen S; Zhang F; Fang X
Cell Biol Int; 2020 Mar; 44(3):882-893. PubMed ID: 31829474
[TBL] [Abstract] [Full Text] [Related]
3. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.
Kim YJ; Hwang KC; Kim SW; Lee YC
Int J Med Sci; 2018; 15(6):610-616. PubMed ID: 29725252
[TBL] [Abstract] [Full Text] [Related]
4. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract] [Full Text] [Related]